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Introduction
The World Health Organization (WHO) defi nes 
stroke as the sudden  onset of a neurologic defi cit 
accompanied by a focal dysfunction and symptoms 
lasting more than 24 hours, which is not caused by 
a traumatic vascular problem. Transient ischemic 
attacks (TIAs) are focal neurologicak events 
resolving completely within 24 hours. A reversible 
ischemic neurologic defi cit (RIND) is defi ned as 
a focal neurological event that resolves within 3 
days to 3 weeks. A variety of conditions may mimic 
stroke, including complex migraine with hemiparesis, 
postictal paralysis (Todd paralysis), hypoglycemia, 
cerebral tumors, cerebral infections or encephalitis, 
subdural hematoma, multiple sclerosis, and malignant 
hypertension. Misdiagnosis is more cummon in 
younger patinets or those who present with complex 
or atypical symptoms [3].
Thrombotic and embolic infarctions of the brain 
are major causes of human morbidity and mortality. 
Eighty-fi ve percent of strokes are ischemic, whereas 
the remaining fi fteen percent are hemorrhagic. The 
1-month mortality for stroke varies with etiology: 
15% for ischemic stroke, 50% for subarachnoid 
hemorrhage (SAH), and 80% or greater with 
intracerebral hemorrhage (ICH). Concurrent 
cardiovascular disease, pulmonary complications, 
and recurrent stroke may complicate patient recovery. 
Fully 25% to 40% of patients will have a repeat stroke 
within 5 years of their initial insult [18].
Risk factors for stroke include systolic and 
diastolic hypertension; advancing age; cardiovascular 
factors including atrial fi brillation, ischemic disease, 
cardiomyopathy and mechanical valves; diabetes; 
smoking; nonwhite racial background; male sex; 
and heavy alcohol use. TIAs are strong predictors 
of risk, with 12% of those with TIAs going on to 
experience a signifi cant stroke within 12 months. 
Most strokes however, are not preceded by a TIA 
[19].
The target times and goals are recommendet 
by the National Institute of Neurological Disorders 
and Stroke (NINDS), which has recommended 
measurable goals for the evaluation of stroke patients. 
These targets or goals should be achieved for at least 
80% of patients with acute stroke [25].
The ECG does not take priority over obtaining 
a computed tomografhy (CT) scan. No arrhythmias 
are specifi c for stroke, but the ECG may identify 
evidence of a recent AMI or arrhythmias such as atrial 
fi brillation as a cause of an eambolic stroke. Many 
pacient with stroke may demonstrate arrhythmias, 
but if the patient is hemodynamically stable, most 
arrhythmias will not require treatment. There is 
general agreement to recommend cardiac monitoring 
during the fi rst 24 hours of evaluation in patients with 
acute ischemic stroke to detect atrial fi brillation and 
potenially life-threatining arrhythmias [18].
Drugs for stroke




Figure 1. Types of stroke. Eighty-seven percent of strokes are ischemic and potentially eligible for fi brinolytic 
therapy if patients otherwise qualify. Thirteen percent of strokes are hemorrhagic, and the majority of these 
are intracerebral. The male-to-female incidence ratio is 1.25 in persons 55 to 64 years of age, 1.50 in those 
65 to 74, 1.07 in those 75 to 84, and 0.76 in those 85 and older. Blacks have almost twice the risk of fi rst-ever 




The major types of stroke are:
Ischemic stroke: accounts for 87% of all • 
strokes and is usually caused by an occlusion of an 
artery to a region of the brain (fi gure 1).
Hemorrhagic stroke: accounts for 13% of • 
all strokes and occurs when a blood vessel in the 
brain suddenly ruptures into the surrounding tissue. 
Fibrinolytic therapy is contraindicated in this type of 
stroke. Avoid anticoagulants [15].
Approach to Stroke Care
Stroke remains a leading cause of death in the 
United States.
Early recognition of acute ischemic stroke is 
important because IV fi brinolytic treatment should 
be provided as early as possible, generally within 3 
hours of onset of symptoms, or within 4.5 hours of 
onset of symptoms for selected patients. Most strokes 
occur at home, and only half of acute stroke patients 
use EMS for transport to the hospital. Stroke patients 
often deny or try to rationalize their symptoms. Even 
high-risk patients, such as those with atrial fi brillation 
or hypertension, fail to recognize the signs of stroke. 
This delays activation of EMS and treatment, resulting 
in increased morbidity and mortality [21].
Community and professional education is 
essential, and it has been successful in increasing 
the proportion of eligible stroke patients treated with 
fi brinolytic therapy [18].
The goal of stroke care is to minimize brain injury 
and maximize the patient’s recovery. The Stroke 
Chain of Survival (fi gure 2) described by the AHA 
and the American Stroke Association is similar to the 
Chain of Survival for sudden cardiac arrest. It links 
actions to be taken by patients, family members, and 
healthcare providers to maximize stroke recovery. 
These links are (23,”/):
Rapid recognition and reaction to stroke • 
warninig signs.
Rapid EMS dispatch.• 
Rapid EMS system transport and prearrival • 
notifi cation to the receiving hospital.
Rapid • diagnosis and treatment in the 
hospital.
The 8 D´s of Stroke Care highlight the major 
steps in diagnosis and treatment of stroke and key 
points at which delays can occur [20]:
Detection: Rapid recognition of stroke • 
symptoms.
Dispatch: Early activation and dispatch of • 
EMS by 903 [112].
Delivery: Rapid EMS identifi cation, • 
management, and transport.
Door: Appropriate triage to stroke center.• 
Data: Rapid triage, evaluation, and • 
management within the ED.
Decision: Stroke expertise and therapy • 
selection.
Drug: Fibrinolytic therapy, intra-arterial • 
strategies.
Disposition: Rapid admission to the stroke • 
unit or critical care unit 
For more information on these critical elements, 
see the Suspected Stroke Algorithm (fi gure 3).
Goals of Stroke Care
The Suspected Stroke Algorithm (fi gure 3) 
emphasizes important elements of out-of-hospital 
care for possible stroke patients. These actions 
include a stroke scale or screen and rapid transport 
to the hospital. As with ACS, prior notifi cation of the 
receiving hospital speeds the care of the stroke patient 
upon arrival (25).
The NINDS has established critical in-hospital 
time goals for assessment and management of patients 
with suspected stroke. This algorithm reviews the 
critical in-hospital time periods for patient assessment 
and treatment [2,4]:
Immediate general assessment by the stroke 1. 
team, emergency physician, or another expert within 
10 minutes of arrival; order urgent noncontrast CT 
scan.
Neurologic assessment by the stroke team or 2. 
designee and CT scan performed within 25 minutes 
of hospital arrival.
Interpretation of t3. he CT scan within 45 
minutes of ED arrival.
Figure 2.  The Stroke Chain of Survival.
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Initiation of fi brinolytic therapy in appropriate 4. 
patients (those without contraindications) within 1 hour 
of hospital arrival and 3 hours from symptom onset.
Door-to-admission time of 3 hours.5. 
Critical Time Periods
Pacients with acute ischemic stroke have a time-
dependent benefi t for fi brinolytic therapy similar to 
that of patients with ST-segment elevation MI, but 
this time-dependent benefi t is much shorter [6].
The critical time period for administration of 
IV fi brinolytic therapy begins with the onset of 
symptoms. Critical time periods from hospital arrival 
are summarized below [4,5]:
Immediate general assessment 10 minutes
Immediate neurologic assessment 25 minutes
Acquisition of CT of the head 25 minutes
Interpretation of the CT scan 45 minutes
Administration of fi brinolytic therapy, 
timed  from ED arrival
60 minutes
Administration of fi brinolytic therapy, 
timed from onset of symptoms
3 hours, or 
4.5 hours in 
selected patients
Admission to a monitored bed 3 hours
Figure 3. The suspected stroke algorithm.
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The signs and symptoms of a stroke:
Sudden weakness or numbness of the face, • 
arm, or leg, especially on one side of the body.
Sudden confusion.• 
Trouble speaking or understanding.• 
Sudden trouble seeing in one or both eyes.• 
Sudden trouble walking.• 
Dizziness or loss of balance or coordination.• 
Sudden severe headache with no known • 
cause.
Stroke Assessment Tools 
The 2010 AHA Guidelines for CPR and ECC 
recommends that all EMS personnel be trained 
to recognize stroke using a validated, abbreviated 
out-of-hospital neurologic evaluation tool such as 
the Cincinnati Prehospital Stroke Scale (CPSS) 
(table 1).
Cincinnati Prehospital Stroke Scale
The CPSS identifi es stroke on the basis of 3 
physical fi ndings:
•  Facial droop (have the patient smile or try to 
show teeth).
•  Arm drift (have the patient close eyes and hold 
both arms out, with palms up).
•  Abnormal speech (have the patient say “You 
can’t teach an old dog new tricks”.
By using the CPSS, medical personnel can evaluate 
the patient in <1 minute. The presence of 1 fi nding on 
the CPSS has a sensitivity of 59% and a specifi city of 
89% when scored by prehospital providers.
With standard training in stroke recognition, 
paramedics demonstrated a sensitivity of 61% to 66% 
for identifying patients with stroke. After receiving 
training in use of a stroke assessment tool, paramedic 
sensitivity for identifying patients with stroke 
increased to 86% to 97% [11].
Critical EMS Assessments and Actions 
(Box 2)
Prehospital EMS must minimize the interval 
between the onset of symptoms and patient arrival in 
the ED. Specifi c stroke therapy can be provided only 
in the appropriate  I receiving hospital ED, so time 
in the fi eld only delays (and may prevent) defi nitive 
therapy. More extensive assessments and initiation 
of supportive therapies can continue en route to the 
hospital or in the ED [12,16].




Support the ABCs and provide 
supplemental oxygen to hypox emic (eg, 
oxygen saturation <94%) stroke patients 





Perform a rapid out-of-hospital stroke 
assessment (CPSS, table 1).
Establish 
time
Determine when the patient was last 
known to be normal or at neurologic 
baseline. This represents time zero. If the 
patient wakes from sleep with symptoms 
of stroke, time zero is the last time the 
patient was seen to be normal.
Triage to 
stroke center
Transport the patient rapidly and 
consider triage to a stroke center. Support 
cardiopulmonary function during 
transport. If possible, bring a witness, 
family member, or caregiver with the 
patient to confi rm time of onset of stroke 
symptoms.
Identify Signs Defi ne and Recognize the Signs of 
Stroke (Box 1)
Alert hospital Provide prearrival notifi cation to the 
receiving hospital.
Check glucose During transport, check blood glucose if 
protocols or medical control allows.
Table 1
The Cincinnati Prehospital Stroke Scale
Test Findings
Facial droop: Have patient show teeth or smile    Normal - both sides of face move equally  
Abnormal - one side of face does not move as well as the 
other side
Arm drift: Patient closes eyes and extends both arms 
straight out, with  palms up, for 10 seconds   
Normal - both arms move the same or both arms do not 
move at all (other fi ndings, such as pronator drift, may be 
helpful)
Abnormal - one arm does not move or one arm drifts down 
compared with the other
Abnormal speech: Have patient say «you can't teach an 
old dog new tricks»  
Normal -patient uses correct words with no slurring
Abnormal - patient slurs words, uses the wrong words, or 
is unable to speak
Interpretation: If any 1 of these 3 signs is abnormal, the probability of a stroke is 72%. The presence of all 3 fi ndings 
indicates that the probability of stroke is >85%.
Modifi ed from Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: repro ducibility 
and validity. Ann Emergency Med. 1999;33:373-378. 
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The patient with acute stroke is at risk for 
respiratory compromise from aspiration, upper airway 
obstruction, hypoventilation, and (rarely) neurogenic 
pulmonary edema. The combination of poor perfusion 
and hypoxemia will exacerbate and extend ischemic 
brain injury, and it has been associated with worse 
outcome from stroke [13,25].
Both out-of-hospital and in-hospital medical 
personnel should provide supplementary oxygen to 
hypoxemic (ie, oxygen saturation <94%) stroke patients 
or patients for whom oxygen saturation is unknown.
In-Hospital, Immediate General Assessment 
and Stabilization (Box 3)
Once the patient arrives in the ED, a number of 
assessments and management activities must occur 
quickly. Protocols should be used to minimize delay 
in defi nitive diagnosis and therapy [7,8].
The goal of the stroke team, emergency physician, 
or other experts should be to assess the patient with 
suspected stroke within 10 minutes of arrival in the 
ED: “Time Is Brain” (Box 3).
Immediate General Assessment and 
Stabilization
ED providers should do the following:
Immediate Neurologic Assessment by Stroke 
Team or Designee (Box 4)
The stroke team, neurovascular consultant, or 
emergency physician does the following [9,10]:
• Reviews the patient’s history, performs a 
general physical examination, and establishes time of 
symptom onset
• Performs a neurologic examination (eg, 
NIHSS)
The goal for neurologic assessment is within 25 
minutes of the patient’s arrival in the ED: “Time Is 
Brain” (Box 4).
Establish Symptom Onset
Establishing the time of symptom onset may 
require interviewing out-of-hospital providers, 
witnesses, and family members to determine the time 
the patient was last known to be normal.
Neurologic Examination
Assess the patient’s neurologic status using one 
of the more advanced stroke scales. Following is an 
example:
National Institutes of Health Stroke Scale
The NIHSS uses 15 items to assess the responsive 
stroke patient. This is a validated measure of stroke 
severity based on a detailed neurologic examination. 
A detailed discussion is beyond the scope of the ACLS 
Provider Course [20].
CT Scan: Hemorrhage or No Hemorrhage 
(Box 5)
A critical decision point in the assessment of 
the patient with acute stroke is the performance and 
interpretation of a noncontrast CT scan to differentiate 
ischemic from hemorrhagic stroke. Assessment also 
includes identifying other structural abnormalities 
that may be responsible for the patient’s symptoms or 
that represent contraindication to fi brinolytic therapy. 
The initial noncontrast CT scan is the most important 
test for a patient with acute stroke.
Assess ABCs Assess the ABCs and evaluate baseline vital signs
Provide oxygen Provide supplemental oxygen to hypoxemic (eg, oxyhemoglobin saturation <94%) 
stroke patients or those patients with unknown oxygen saturation.
Establish IV access and obtain 
blood samples
Establish IV access and obtain blood samples for baseline blood count, coagulation 
studies, and blood glucose. Do not let this delay obtaining a CT scan of the brain.
Check glucose Promptly treat hypoglycemia.
Perform neurologic assessment Perform a neurologic screening assessment. Use the NIH Stroke Scale (NIHSS) or 
a similar tool.
Activate the stroke team Activate the stroke team or arrange consultation with a stroke expert based on 
predetermined protocols.
Order CT brain scan Order an emergent CT scan of the brain. Have it read promptly by a qualifi ed 
physician.
Obtain 12-lead ECG Obtain a 12-lead ECG, which may identify a recent or ongoing AMI or arrhythmias 
(eg, atrial fi brillation) as a cause of embolic stroke. A small percentage of patients 
with acute stroke or transient ischemic attack have coexisting myocardial ischemia 
or other abnormalities. There is general agreement to recommend cardiac monitoring 
during the fi rst 24 hours of evaluation in patients with acute ischemic stroke to 
detect atrial fi brillation and potentially life-threatening arrhythmias.
Life-threatening arrhythmias can follow or accompany stroke, particularly 
intracerebral hemorrhage. If the patient is hemodynami-cally stable, treatment of 
non-life-threatening  arrhythmias (bradycardia, VT, and AV conduction blocks) 
may not be necessary.
Do not delay the CT scan to obtain the ECG.
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• If a CT scan is not readily available, stabilize 
and promptly transfer the patient to a facility with this 
capability.
• Do not give aspirin, heparin, or rtPA until the 
CT scan has ruled out intracranial hemorrhage.
The CT scan should be completed within 25 
minutes of (he patient’s arrival in the ED and should 
be read within 45 minutes from ED arrival: “Time Is 
Brain” (Box 5).
Decision Point: Hemorrhage or No 
Hemorrhage
Additional imaging techniques such as CT 
perfusion, CT angiography, or magnetic resonance 
imaging scans of patients with suspected stroke should 
be promptly interpreted by a physician skilled in 
neuroimaging interpretation. Obtaining these studies 
should not delay initiation of IV rtPA in eligible patients. 
The presence of hemorrhage versus no hemorrhage 
determines the next steps in treatment [20].
Yes, Hemorrhage Is Present
If hemorrhage is noted on the CT scan, the 
patient is not a candidate for fi brinolytics. Consult 
a neurologist or neurosurgeon. Consider transfer for 
appropriate care (Box 7).
No, Hemorrhage Is Not Present
If the CT scan shows no evidence of hemorrhage 
and no sign of other abnormality (eg, tumor, recent 
stroke), the patient may be a candidate for fi brinolytic 
therapy (Boxes 6 and 8).
If hemorrhage is not present on the initial CT scan 
and the patient is not a candidate for fi brinolytics for 
other reasons, consider giving aspirin (Box 9) either 
rectally or orally after performing a swallowing screen. 
Although aspirin is not a time-critical intervention, it 
is appropriate to administer aspirin in the ED if the 
patient is not a candidate for fi brinolysis. The patient 
must be able to safely swallow before aspirin is given 
orally. Otherwise use the suppository form [14,17].
Fibrinolytic Therapy
Several studies have shown a higher likelihood 
of good to excellent functional outcome when rtPA 
is given to adults with acute ischemic stroke within 
3 hours of onset of symptoms, or within 4.5 hours 
of onset of symptoms for selected patients. But these 
results are obtained when rtPA is given by physicians 
in hospitals with a stroke protocol that rigorously 
adheres to the eligibility criteria and therapeutic 
regimen of the NINDS protocol. Evidence from 
prospective randomized studies in adults also 
documents a greater likelihood of benefi t the earlier 
treatment begins.
The AHA and stroke guidelines recommend 
Table 2 
Inclusion and Exclusion Characteristics of Patients With Ischemic Stroke Who Could Be Treated With 
rtPA Within 3 Hours From Symptom Onset*
Inclusion Criteria
Diagnosis of ischemic stroke causing measurable neurologic defi cit• 
Onset of symptoms <3 hours before beginning treatment• 
Age >18 years• 
Exclusion Criteria
Head trauma or prior stroke in previous 3 months• 
Symptoms suggest subarachnoid hemorrhage• 
Arterial puncture at noncompressible site in previous 7 days• 
History of previous intracranial hemorrhage• 
Elevated blood pressure (systolic >185 mm Hg or diastolic >110 mm Hg)• 
Evidence of active bleeding on examination• 
Acute bleeding diathesis, including but not limited to• 
-  Platelet count <100 000/mm3
-  Heparin received within 48 hours, resulting in an aPTT greater than the upper limit of normal
-  Current use of anticoagulant with INR >1.7 or PT >15 seconds
Blood glucose concentration <50 mg/dL (2.7 mmol/L)• 
CT demonstrates multilobar infarction (hypodensity >1/3 cerebral hemisphere)• 
Relative Exclusion Criteria 
        Recent experience suggests that under some circumstances - with careful consideration and weighing of risk to 
benefi t - patients may receive fi brinolytic therapy despite 1 or more relative contraindications. Consider risk to benefi t 
of rtPA administration carefully if any one of these relative contraindications is present:
Only minor or rapidly improving stroke symptoms (clearing spontaneously)• 
Seizure at onset with postictal residual neurologic impairments• 
Major surgery or serious trauma within previous 14 days• 
Recent gastrointestinal or urinary tract hemorrhage (within previous 21 days)• 
Recent acute myocardial infarction (within previous 3 months)• 
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giving IV rtPA to patients with acute ischemic stroke 
who meet the NINDS eligibility criteria if it is given 
by
• Physicians using a clearly defi ned institutional 
protocol.
• A knowledgeable interdisciplinary team familiar 
with stroke care.
• An institution with a commitment to 
comprehensive stroke care and rehabilitation.
The superior outcomes reported in both 
community and tertiary care hospitals in the NINDS 
trials can be diffi cult to replicate in hospitals with less 
experience in, and institutional commitment to, acute 
stroke care. There is strong evidence to avoid all 
delays and treat patients as soon as possible. Failure 
to adhere to protocol is associated with an increased 
rate of complications, particularly risk of intracranial 
hemorrhage [26].
Evaluate for Fibrinolytic Therapy (Box 6)
If the CT scan is negative for hemorrhage, the 
patient may be a candidate for fi brinolytic therapy. 
Immediately perform further eligibility and risk 
stratifi cation:
• If the CT scan shows no hemorrhage, the 
probability of acute ischemic stroke remains. Review 
inclusion and exclusion criteria for IV fi brinolytic 
therapy (table 2) and repeat the neurologic exam 
(NIHSS or Canadian Neurological Scale).
• If the patient’s neurologic function is rapidly 
improving toward normal, fi brinolytics may be 
unnecessary.
Abbreviations: aPTT, activated partial 
thromboplastin lime; INR, international normalized 
ratio; PT, pro thrombin time; rtPA, recombinant tissue 
plasminogen activator.
Potential Adverse Effects
As with all drugs, fi brinolytics have potential 
adverse effects. At this point weigh the patient’s risk 
for adverse events against the potential benefi t and 
discuss with the patient and family.
Confi rm that no excl• usion criteria are present 
(table 5).
Cons• ider risks and benefi ts.
Be prepared to monitor and treat any potential • 
complications.
The major complication of IV rtPA for 
stroke is intracranial hemorrhage. Other bleeding 
complications may occur and may range from minor 
to major. Angioedema and transient hypotension may 
occur.
Patient is a Candidate for Fibrinolytic Therapy 
(Boxes 8 and 10)
If the patient remains a candidate for fi brinolytic 
therapy (Box 8), discuss the risks and potential 
benefi ts with the patient or family if available (Box 
10). After this discussion, if the patient or family 
members decide to proceed with fi brinolytic therapy, 
give the patient rtPA. Begin your institution’s stroke 
rtPA protocol, often called a “pathway of care.”
Do not administer anticoagulants or antiplatelet 
treatment for 24 hours after administration of rtPA, 
typically until a follow-up CT scan at 24 hours shows 
no intracranial hemorrhage.
Extended IV rtPA Window 3 to 4.5 Hours
Treatment of carefully selected patients with 
acute ischemic stroke with IV rtPA between 3 and 4.5 
hours after onset of symptoms has also been shown 
to improve clinical outcome, although the degree 
of clinical benefi t is smaller than that achieved with 
treatment within 3 hours. Data supporting treatment 
in this time window come from a large, randomized 
trial (ECASS-3 [European Cooperative Acute Stroke 
Study]) that specifi cally enrolled patients between 3 
and 4.5 hours after symptom onset, as well as a meta-
analysis of prior trials [24]. 
At present, use of IV rtPA within the 3- to 4.5-
hour window has not yet been approved by the US 
Food and Drug Administration (FDA), although 
it is recommended by an AHA/American Stroke 
Association science advisory. Administration of IV 
rtPA to patients with acute ischemic stroke who meet 
the NINDS or ECASS-3 eligibility criteria (table 3) is 
recommended if rtPA is administered by physicians 
in the setting of a clearly defi ned proto col, a 
knowledgeable team, and institutional commitment.
Abbreviations: FDA, Food and Drug 
Administration; INR, international normalized ratio; 
NIHSS, National Institutes of Health Stroke Scale; 
PT, prothrombin time; rtPA, recombinant tissue 
plasminogen activator.
*del Zoppo GJ, Saver JL, Jauch EC, Adams 
HP Jr; on behalf of the American Heart Association 
Stroke Council. Expansion of the time window for 
treatment of acute ischemic stroke with intravenous 
tissue plasminogen activator: a science advisory 
from the American Heart Association/American 
Stroke Association. Stroke. 2009;40:2945-2948.
Intra-arterial rtPA
Improved outcome from use of cerebral intra-
arterial rtPA has been documented. For patients 
with acute ischemic stroke who are not candidates 
for standard IV fi brinolysis, consider intra-arterial 
fi brinolysis in centers with the resources and expertise 
to provide it within the fi rst 6 hours after onset of 
symptoms. Intra-arterial administration of rtPA is not 
yet approved by the FDA [24].
The general care of all patients with stroke 
includes the following:
Begin stroke pathway.• 
Support airway, breathing, and circulation.• 
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Monitor blood glucose.• 
Monitor blood pressure.• 
Monitor temperature.• 
Perform dysphagia screening.• 
Monitor for complications of stroke and • 
fi brinolytic therapy.
Transfer to general intensive care if • 
indicated.
Begin Stroke Pathway (Boxes 11 and 12)
Admit patients to a stroke unit (if available) for 
careful observation (Box 11), including monitoring 
of blood pressure and neurologic status. If neurologic 
status worsens, order an emergent CT scan. Determine 
if cerebral edema or hemorrhage is the cause; consult 
neurosurgery as appropriate. Additional stroke 
care includes support of the airway, oxygenation, 
ventilation, and nutrition. Provide normal saline to 
maintain intravascular volume (eg, approximately 75 
to 100 mL7h) if needed.
Monitor Blood Glucose
Hyperglycemia is associated with worse clinical 
outcome in patients with acute ischemic stroke. But 
there is no direct evidence that active glucose control 
improves clinical outcome. There is evidence that 
insulin treatment of hyperglycemia in other critically 
ill patients improves survival rates. For this reason, 
consider giving IV or subcutaneous insulin to lower 
blood glucose in patients with acute ischemic stroke 
when the serum glucose level is >185 mg/dL [1].
Monitor for Complications of Stroke and 
Fibrinolytic Therapy
Prophylaxis for seizures is not recommended. 
Table 3 
Inclusion and Exclusion Characteristics of Patients With Ischemic Stroke Who Could Be Treated With 
rtPA From 3 to 4.5 Hours From Symptom Onset”
Inclusion Criteria
Diagnosis of ischemic stroke causing measurable neurologic defi cit• 
Onset of symptoms 3 to 4.5 hours before beginning treatment• 
Exclusion Criteria
Age >80 years• 
Severe stroke (NIHSS >25)• 
Taking an oral anticoagulant regardless of INR• 
History of both diabetes and prior ischemic stroke• 
Notes
The checklist includes some US FDA-approved indications and contraindications for administration • 
of rtPA for acute ischemic stroke. Recent AHA/ASA guideline revisions may differ slightly from FDA 
criteria. A physician with expertise in acute stroke care may modify this list.
Onset time is either witnessed or last known normal.• 
In patients without recent use of oral anticoagulants or heparin, treatment with rtPA can be initiated before • 
availability of coagulation study results but should be dis continued if INR is >1.7 or PT is elevated by 
local laboratory standards.
In patients without a history of thrombocytopenia, treatment with rtPA can be initiated before availability • 
of platelet count but should be discontinued if platelet count is <100 000/mm3.
Table 4 
Potential Approaches to Arterial Hypertension in Patients With Acute Ischemic Stroke Who Are Potential 
Candidates for Acute Reperfusion Therapy*
Patient otherwise eligible for acute reperfusion therapy except that blood pressure is >185/110 mm Hg:
Labetalol 10-20 mg IV over 1 -2 minutes, may repeat x 1, or• 
Nicardipine IV 5 mg per hour, titrate up by 2.5 mg per hour every 5-15 minutes, maximum 15 mg per hour; when • 
desired blood pressure is reached, lower to 3 mg per hour, or
Other agents (hydralazine, enalaprilat, etc) may be considered when appropriate• 
If blood pressure is not maintained at or below 185/110 mm Hg, do not administer rtPA.
Management of blood pressure during and after rtPA or other acute reperfusion therapy:
Monitor blood pressure every 15 minutes for 2 hours from the start of rtPA therapy, then every 30 minutes for 6 
hours, and then every hour for 16 hours. 
If systolic blood pressure 180-230 mm Hg or diastolic blood pressure 105-120 mm Hg:
Labetalol 10 mg IV followed by continuous IV infusion 2-8 mg per minute, or• 
Nicardipine IV 5 mg per hour, titrate up to desired effect by 2.5 mg per hour every 5-15 minutes, maximum 15 mg • 
per hour
If blood pressure not controlled or diastolic blood pressure >140 mm Hg, consider sodium nitroprusside.
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But treatment of acute seizures followed by 
administration of anticonvulsants to prevent further 
seizures is recommended.  Monitor the patient for 
signs of increased intracranial pressure. Continue to 
control blood pressure to reduce the potential risk of 
bleeding.
Hypertension Management in rtPA 
Candidates
Although management of hypertension in the 
stroke patient is controversial, patients who are 
candidates for fi brinolytic therapy should have 
their blood pressure controlled to lower the risk of 
intracerebral hemorrhage following administration 
of rtPA. General guidelines for the management of 
hypertension are outlined in Tables 4 and 5.
If patient is eligible for fi brinolytic therapy, 
blood pressure must be <185 mm Hg systolic and 
≤ 110 mm Hg diastolic to limit the risk of bleeding 
complications. Because the maximum interval from 
onset of stroke until effective treatment of stroke 
with rtPA is limited, most patients with sustained 
hypertension above these levels will not be eligible 
for IV rtPA.
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Rezumat
Datele recente statistice ne demonstrează că 29-65% 
din pacienţii cu semne şi simptome de accident vascular 
cerebral acut accesează asistenţa medicală la etapa iniţială 
prin serviciul de asistenţă medicală de urgenţă, ceea ce ne 
atestă rolul serviciului AMU în lanţul de supravieţuire. 
Crearea centrelor (secţiilor) specializate cu unităţi de 
stroke asigurate cu personal, programe, protocoale şi 
infrastructură pentru acordarea asistenţei medicale de 
urgenţă a pacienţilor cu AVC şi posibilităţi de aplicare a 
metodelor de tratament intensiv (ca tratamentul intravenos 
cu rt PA) şi spitalizarea pacienţilor în unitatea de stroke. 
Unitatea de stroke este destinată pentru acordarea asistenţei 
medicale pacienţilor cu hemoragii intracerebrale şi a celor 
care necesită intervenţii specifi ce (chirurgie sau proceduri 
endovasculare) sau terapie intensivă. Sunt recomandate 
prezenţa protocoalelor de evaluare a pacienţilor cu AVC şi 
a unei echipe de stroke care să includă medici specialişti, 
asistenţi medicali, medic imagist, laboranţi şi laborant 
radiolog. Administrarea intravenoasă a rt PA (0,9 mg/kg, 
maximum 90 mg) este recomandată pacienţilor selectaţi 
în primele < 3 ore de la apariţia primelor semne de AVC 
ischemic. Tromboliza intra-arterială este o obţiune pentru 
tratamentul pacienţilor cu AVC selectaţi până la < 6 ore 
cauzate de ocluzia ACM şi care nu sunt candidaţi pentru 
rtPA. Managementul corect al pacientului cu AVC în 
primele ore de spitalizare constituie elementul-cheie, cel 
mai important, de terapie intensivă. Terapiile şi intervenţiile 
aplicate ameliorează prognosticul prin micşorarea 
complicaţiilor şi termenelor de recuperare a pacienţilor. 
Summary
Recent data indicate that 29-65% of patients with signs 
or symptoms of acute stroke access their initial medical via 
local EMS which confi rm the role of EMS in the chain of 
survival. The creation of stroke centers with the personnel 
programs expertise and infrastructure to cave for many 
patients with strokes, uses many acute therapies (such as 
intravenous rtPA) and admit such patients into a stroke unit. 
Stroke unit is designed to care for patients with complicated 
typs of strokes, patients with intracerebral hemorrhage or 
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subarachnoid hemorrhage, and those requiring specifi c 
interventions (surgery or endovascular procedures) or an 
intensive cave. An organized protocol for the emergency 
evaluation of patients with strokes, designation of an acute 
stroke team that includes physicians, nurses and laboratory/
radiology personnel is recommended. Intravenous rtPA 
(0.9 mg/kg, maximum dose 90 mg) is recommended for 
selected patients who may be treated within 3 hours of onset 
of ischemic stroke. Intra-arterial thrombolysis is an option 
for treatment of selected patients who have major stroke of 
< 6 hours duration due to occlusions of the MCA and who 
ave not candidates for intravenous rtPA. The management 
of patients after admission to the hospital remains a key 
component of overall treatment and it is as important 
as the acutely administered therapies. These therapies 
can improve outcomes by lessening complications and 
speeding recovery from stroke.   
Резюме
Новые статистические данные показывают, что 
29-65% больных с клиническими проявлениями остро-
го нарушения мозгового кровообращения обращаются 
за медицинскую помощь через службу скорой помощи, 
что говорит о значимости данной службе в выживании 
этих больных. Создание центров (специализирован-
ных отделении) с блоками интенсивной терапии осна-
щенными специально обученным персоналом, про-
токолами, экспертизам и соответствующей организа-
ционной структурой для оказания ургентной помощи 
больным  с инсультами с использованием методов ин-
тенсивной терапии (внутривенное введение тромболи-
тиков – rtPA) и лечение больных в блоке интенсивной 
терапии. Блок интенсивной терапии предназначен для 
лечения больных с внутримозговыми кровоизлияния-
ми и больных которые нуждаются в специфическими 
процедурами (хирургические или эндоваскулярные) а 
также больных нуждающиеся в интенсивной терапии. 
В этих центрах обследования для лечения больных с 
инсультами рекомендовано наличие протоколов и спе-
циально обученной бригады состоящей из врачей спе-
циалистов, медицинских сестер, лаборантов и рентген-
лаборантов. Внутривенное введение rtPA (0,9 mг/kg, 
максимум 90 мг) рекомендовано больным с показания-
ми у которых прошло менее 3 часов с момента возник-
новения первых симптомов ишемического инсульта. 
Интраартериальное введение тромболитиков является 
методом выбора для лечения больных с показаниями, 
у которых с момента возникновения первых признакам 
ишемического инсульта вследствие окклюзии средне-
исонной мозговой артерии не прошло более 6 часов. 
Правильный менеджмент больных с инсультами в пер-
вые часы после госпитализации составляет ключевое 
звено в проведении интенсивной терапии. Интенсив-
ная терапия и проведенные лечебные процедуры улуч-
шает  прогноз больных путем снижения осложнений и 
ускорения сроков выздоровления.
